Our Pricing

Buy Mounjaro Jab Online UK - Fast Prescription Service

Published on: June 03, 2026

When you buy Mounjaro jab online UK through Cured Pharmacy, you'll receive genuine tirzepatide weight loss injections from £135.00 dispensed by our UK-registered team following a free clinical consultation. Our transparent pricing and fast prescription service make accessing this MHRA-licensed treatment straightforward and discreet.

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for weight management [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation and metabolic control.

In the SURMOUNT-1 clinical trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly greater than results seen with single-agonist alternatives [1]. The dual mechanism helps regulate blood glucose levels, slows gastric emptying, and reduces hunger signals to the brain, creating multiple pathways for sustainable weight management.

Patients typically start on a lower dose and gradually increase over several months, allowing the body to adjust and minimising potential side effects. This titration schedule is determined by your UK prescriber based on your individual response and tolerability.

Mounjaro vs Wegovy: Comparing Weight Loss Injections

Both Mounjaro and Wegovy are once-weekly injectable treatments licensed by the MHRA for weight management, but they work through different mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro's tirzepatide activates both GIP and GLP-1 receptors [1][2].

Head-to-head trials suggest tirzepatide may produce greater average weight reduction than semaglutide, though individual responses vary considerably [3]. The choice between treatments depends on your medical history, previous treatment responses, and prescriber assessment rather than efficacy data alone.

Which Treatment Is Right for You?

Your UK prescriber will assess factors including your BMI, existing health conditions, current medications, and weight loss goals during your consultation. Some patients may be better suited to daily injections like Saxenda, whilst others benefit from the convenience of weekly dosing. Our clinical team evaluates each case individually to recommend the most appropriate option, subject to clinical suitability.

Buy Mounjaro Jab Online UK: The Cured Pharmacy Process

When you buy Mounjaro jab online UK through our pharmacy, the process begins with a free online consultation taking under three minutes. You'll answer questions about your medical history, current medications, and weight management goals — information our UK-registered prescribers use to determine clinical suitability.

If approved, your prescription is issued electronically and sent to our dispensary, where our GPhC-registered pharmacists prepare your medication for discreet delivery. We provide transparent upfront pricing at £135.00 before you begin the consultation, so there are no unexpected costs or hidden fees.

All Mounjaro supplied by Cured Pharmacy is sourced through UK-licensed wholesalers and stored in our temperature-controlled facilities to maintain product integrity. Your medication arrives in discreet packaging with full patient information leaflets and injection guidance.

Prescription Requirements

Mounjaro is a prescription-only medicine in the UK and cannot be supplied without clinical assessment by a registered prescriber. Our online consultation meets all MHRA and GPhC requirements for remote prescribing, ensuring the same clinical standards as face-to-face consultations. If our prescriber determines Mounjaro is not suitable for you, they may suggest alternative treatments or recommend speaking with your GP.

Mounjaro Dosing and Administration

Mounjaro KwikPen injections are administered subcutaneously once weekly, typically in the abdomen, thigh, or upper arm. The pen device is pre-filled and designed for self-administration at home, with clear instructions provided in the patient information leaflet.

The standard titration schedule begins at 2.5mg weekly for four weeks, increasing to 5mg for the next four weeks, then potentially to 7.5mg, 10mg, 12.5mg, or 15mg depending on individual response and tolerability [4]. Your prescriber determines the appropriate maintenance dose based on weight loss progress and how well you tolerate the medication.

Each pen should be stored in the refrigerator between 2°C and 8°C until use, though it may be kept at room temperature for up to 21 days if needed. Never freeze Mounjaro pens, and always inspect the solution before injection — it should be clear and colourless.

Common Side Effects and What to Expect

The most frequently reported side effects with Mounjaro are gastrointestinal in nature, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [4]. These effects are typically mild to moderate and often diminish as your body adjusts to the medication, particularly with gradual dose escalation.

In clinical trials, nausea occurred in approximately 20-30% of participants, though most cases resolved within the first few weeks of treatment [1]. Starting with smaller meals, avoiding high-fat foods, and staying well-hydrated can help manage these symptoms. If side effects become severe or persistent, contact your prescriber — they may adjust your dose or recommend alternative management strategies.

Serious side effects are rare but can include pancreatitis, gallbladder problems, and severe allergic reactions. Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, or symptoms of thyroid tumours such as a lump in the neck or difficulty swallowing.

Managing Gastrointestinal Symptoms

Our clinical team recommends eating smaller, more frequent meals rather than large portions, choosing bland foods during the initial adjustment period, and avoiding lying down immediately after eating. These practical adjustments can significantly reduce the intensity of nausea and other digestive symptoms whilst your body adapts to treatment.

Who Can Use Mounjaro for Weight Loss?

Mounjaro is licensed in the UK for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidaemia [4]. Your prescriber will calculate your BMI during the consultation and assess whether you meet the clinical criteria for treatment.

Certain medical conditions may preclude Mounjaro use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic ketoacidosis. Pregnant or breastfeeding women should not use Mounjaro, and effective contraception is recommended during treatment due to potential risks.

Our UK prescribers review your complete medical history, including current medications, to identify any contraindications or potential drug interactions. This thorough assessment ensures Mounjaro is both safe and appropriate for your individual circumstances before any prescription is issued.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
4. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.